HDL Cholesterol

You were probably taught that HDL is your good cholesterol and that a high number earns a gold star. The research has moved past that. Low HDL-C still tracks higher risk in most people, but very high HDL-C is not a bonus, and in several large studies it goes with more deaths, not fewer.

That makes this a number worth understanding rather than cheering. It tells you something real about your metabolic and heart health, but only when you read it beside ApoB, LDL-C, triglycerides, glucose, blood pressure, and the reason the test was drawn.

What This Number Actually Measures

This test measures HDL-C in the clear fluid part of a blood sample. HDL-C stands for high-density lipoprotein cholesterol. It is the amount of cholesterol riding inside a class of small, dense blood particles.

The main protein scaffold is called apolipoprotein A-I. Your liver and small intestine make the starting material, and the particles pick up cholesterol from cells as they circulate.

HDL particles help carry cholesterol from your tissues back to the liver. Researchers call this reverse cholesterol transport. But the HDL-C number tells you how much cholesterol is sitting inside those particles, not how well the particles work. One number compresses a complicated cleanup system, so cholesterol content is an imperfect stand-in for HDL protection.

Why Low HDL Still Matters

In most general populations, low HDL-C tracks higher risk of dying from heart disease. A dose-response analysis pooling 14 prospective reports with more than a million participants found that higher HDL-C went with lower cardiovascular death, about 40% lower risk when the highest and lowest groups were compared. A prospective cohort of 3.3 million Chinese adults and a study of about 632,000 Canadians without prior heart disease both linked lower HDL-C to higher cardiovascular death.

Low HDL-C rarely travels alone. It tends to show up with obesity, smoking, insulin resistance, metabolic syndrome, diabetes, and chronic kidney disease. Insulin resistance means your body needs more insulin than it should to keep blood sugar controlled. A low value is often a flag for the whole metabolic picture rather than an isolated lipid problem. It can also drop during whole-body illness.

The signal reaches beyond the heart, but the evidence there is more associative. In a German outpatient dataset of about 62,000 people, low HDL-C was linked to higher odds of cancer. Two Danish population cohorts totaling nearly 117,000 people tied low HDL-C to several cancers, most strongly blood and nervous-system cancers. Idiopathic pulmonary arterial hypertension is a rare disease of the lung blood vessels. In that condition, lower HDL-C predicted worse survival.

When Higher Stops Being Better

This is where the good-cholesterol story breaks. In two large Copenhagen cohorts, all-cause mortality followed a U-shape: lowest around 73 mg/dL in men and 93 mg/dL in women, then climbing again at the extremes. Men with HDL-C at or above 116 mg/dL had about twice the risk of death, and women at or above 135 mg/dL had roughly two-thirds higher risk. A meta-analysis of extremely high HDL-C reached the same conclusion, and a study of about 173,000 Korean adults without diabetes found the highest HDL-C group carried about a third higher death risk in men.

Higher HDL-C has also been linked to MRI markers that can reflect subtle scarring and stiffening in the heart muscle. In MESA, a multi-ethnic community study, higher HDL-C was tied to those markers, while low HDL-C was not. This was cross-sectional, so it cannot show that high HDL-C caused the heart changes.

So how can both low and very high HDL-C be bad? The trap is picturing HDL-C as a good-number, bad-number dial. It is better read as a readout of underlying biology. A very high value can reflect large or less effective HDL particles, heavy alcohol intake, genetic variants, or shifts in how your body handles triglycerides. The number rose, but the protection did not rise with it. Different levels can flag different problems, which is why this is a context marker, not a target to push in one direction.

Diabetes Changes the Rules

Diabetes status and sex both change what an HDL-C value means, so the same number is not read the same way for everyone.

Sources: Wu et al. 2021; Davis et al. 2024.

If you have diabetes or hypertension, do not read a high HDL-C as reassurance. In hypertensive patients, a study of nearly 12,000 people found both low and high HDL-C linked to more cardiovascular events in men. In these groups, HDL-C seems to have a middle zone rather than a higher-is-always-better pattern, and both tails deserve attention beside the rest of your workup.

Why the Number Undersells the Biology

Because HDL-C measures cargo rather than function, tests that capture what HDL does can predict outcomes better in some settings. The clearest example is cholesterol efflux capacity. This measures how well HDL helps pull cholesterol out of cells. In a study of nearly 1,000 people, each step up in efflux capacity went with about 25% lower odds of coronary disease after accounting for HDL-C. A later study of about 2,900 people found the highest efflux group had roughly two-thirds lower cardiovascular risk, while HDL-C itself was not predictive.

Those studies measured efflux capacity, a related but different thing from the HDL-C on your lab report. They explain why the number falls short; they do not directly reinterpret your HDL-C value. The evidence here is not unanimous, since at least one large genetic and observational study found efflux capacity added nothing over HDL-C once other lipid measures were accounted for. The same pattern shows up with particle counting. In a coronary artery disease cohort, higher concentrations of small HDL particles went with lower mortality, whereas HDL-C was much less informative. Attempts to raise HDL-C with drugs have not reduced cardiovascular events through HDL-C itself, which is the strongest argument that the concentration alone is not something to treat.

When a Single Reading Can Fool You

Acute illness is the biggest source of a misleading value. HDL-C falls during infection and critical illness. In sepsis studies, people who did not survive had HDL-C about 7 mg/dL lower at ICU admission, which reflects how sick they were rather than their baseline lipid risk. A blood draw during the weeks around an infection, surgery, or hospital stay can understate your usual HDL-C.

Some drugs lower HDL-C without causing the metabolic or heart disease the number usually flags. Beta-blockers and anabolic-androgenic steroids can push it down; thiazide-type diuretics can affect the lipid pattern, but their HDL-C effect is smaller and less consistent. If one of these is in the picture, note it before you interpret a low result.

Alcohol can fool you in the other direction. Regular drinking can raise HDL-C, but that does not mean better artery protection. A higher result from alcohol is a reason to look harder at the rest of the risk picture, not a reason to keep drinking.

HDL-C also drifts on its own. Under controlled conditions the within-person swing is small, about 3% over a few days. In real-world repeat sampling it runs closer to 8% to 12% over a year, and most of that is genuine biological variation rather than lab error. A borderline value can read differently on a repeat test, which is the case for not acting on one number alone.

Why One Reading Is Not Enough

Given that variation, a trend beats any single snapshot. Two values a week apart can differ just from normal fluctuation. Studies of repeat testing suggest spacing samples at least four days apart to estimate your true level. Use more than one measurement before drawing conclusions, especially near a borderline result.

Tracking also tells you something the number alone cannot. A falling HDL-C over time can be an early hint of worsening metabolic health, especially if triglycerides or glucose are rising too. A rise from exercise or weight loss means more than the same rise from a drug or alcohol, because the surrounding biology moved with it.

What to Do With an Out-of-Pattern Result

If your HDL-C is low, look at the company it keeps. Check triglycerides, fasting glucose or HbA1c, waist size, blood pressure, and hs-CRP. hs-CRP is a blood marker of inflammation. Low HDL-C with high triglycerides and rising glucose points toward insulin resistance, and the triglyceride-to-HDL ratio is a useful read on that pattern. That combination, not the HDL-C number by itself, should drive action.

If your HDL-C is unusually high, resist the urge to celebrate. Pair it with ApoB or non-HDL cholesterol. ApoB counts artery-clogging particles; non-HDL cholesterol totals the cholesterol inside them. These usually tell you more about heart attack risk than HDL-C will. An extreme value, especially with diabetes, hypertension, heavy alcohol intake, or a strong family history, is worth discussing with a lipid specialist. They may consider particle or function testing to see whether high HDL-C reflects useful HDL function or less effective particles. HDL-C is one input into a larger picture, never the verdict on its own.